Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Cancer Res. 2018 Jul 10;16(10):1470–1482. doi: 10.1158/1541-7786.MCR-18-0322

Figure 2. High level of LINC00152 expression is associated with poor patient prognosis in GBMs, LGGs and many other tumors.

Figure 2

A) Kaplan Meier of GBM patients separated into the top 33% highest expressing LINC00152 cohort and lower expressing cohort. B) Kaplan Meier of LGG patients separated into the 33% highest expressing LINC00152 cohort and lower expressing cohort. C–F) Kaplan Meier plots of the highest LINC00152 expressing quartile and lowest LINC00152 expressing quartiles for head and neck squamous carcinoma, lung adenocarcinoma, renal clear cell carcinoma, and hepatocellular carcinoma, respectively. Hazard ratio is indicated as “HR” and the 95% confidence interval is indicated as “CI”.